American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (936)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (898)
  10. Tow Center for Developmental Oncology (TCDO) (863)
Search Within
Formats
  1. Meeting Abstract (3939)
  2. Journal Article (1239)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (328)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (292)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (43)
  2. 2024 (217)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (4951)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5323)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cerebral hemodynamics improve in adults with sickle cell disease after gene therapy
    Meeting Abstract

    Sharma, A.; Hankins, J. S.; Boelens, J. J.; Cancio, M.; Peddinti, R.; Rispoli, L.; Sloan, S.; Costa, S. D.; Peled, S.; Wiethoff, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Proliferation of a novel CD3(neg) hyperactivated T-cell population characterizes adult hemophagocytic lymphohistiocytosis and associates with disease activity
    Meeting Abstract

    Rocco, J. M.; Laidlaw, E.; Yates, B.; Schroeder, B.; Limerick, E.; Johnson, W. T.; Oved, J. H.; Galindo, F.; Ewing, W.; Fitzhugh, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • GVHD therapy with ruxolitinib is frequently associated with cytopenias, but significant decline in hemoglobin level was only observed in non-responders at day 28
    Meeting Abstract

    Gergoudis, S.; Devlin, S. M.; Susman, P.; Singh, A.; Chinapen, S.; Perales, M. A.; Ponce, D. M.
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy of budesonide monotherapy for low grade GI GVHD after post transplant cyclophosphamide
    Meeting Abstract

    Cook, M.; Vadakkel, G.; Chinapen, S.; Perales, M. A.; Tamari, R.; Papadopoulos, E. B.; Ponce, D. M.; Shaffer, B. C.; Lin, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Dietary sucrose exacerbates antibiotic-induced microbiome injury in allo-HCT
    Meeting Abstract

    Rangesa, M.; Dai, A.; Adintori, P.; Jogia, W.; Fei, T.; Waters, N.; Baichoo, M.; Ballweg, A.; Sahu, S.; Schluter, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Evaluation of teclistamab in BCMA-directed therapy exposed versus naive in relapsed/refractory multiple myeloma
    Meeting Abstract

    Snyder, J.; Graf, K.; Davis, J. A.; McKenna, M.; Tiger, Y. K.; Laharwal, M. M.; Mewawalla, P.; Alkharabsheh, O.; Hashmi, H.; Shaikh, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A multicenter, open-label, phase 1 clinical trial of AJ1-11095 administered as oral monotherapy in patients with primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia myelofibrosis (PET-MF) who have been failed by a type I JAK2 inhibitor (JAK2i)
    Meeting Abstract

    Mascarenhas, J. O.; Borate, U.; Bose, P.; Byrd, J. C.; Garcia, J. S.; Grunwald, M. R.; Hobbs, G. S.; Hoffman, R.; Kuykendall, A. T.; Mesa, R. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A real-world analysis of the safety and efficacy of teclistamab for patients with relapsed/refractory multiple myeloma and baseline renal impairment
    Meeting Abstract

    Habib, A.; Khan, A. M.; Laharwal, M. M.; Mewawalla, P.; McKenna, M.; Tiger, Y. K.; Shaikh, H.; Strouse, C.; Green, K. M.; Davis, J. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Representation of older adults in FDA and EMA registrational trials for diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Juthani, R.; Pugh, K.; Neuendorff, N.; Torka, P.
    Blood (2024)

    Fulltext@MSK | Save
  • The burden of hematologic malignancies in Southeast Asia from 1990 to 2021: Estimates from the Global Burden of Disease Study
    Meeting Abstract

    Ho, F. D. V.; Dee, E. C.; Feliciano, E. J. G.; Jain, U.; Sekolar, A.; Jain, B.; Columbres, R. C.; Swami, N.; Wu, J. F.
    Blood (2024)

    Fulltext@MSK | Save